HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[Effects of ulinastatin on renal ultrastructure after ischemia-reperfusion in rats].

AbstractOBJECTIVE:
To investigate the effect of ulinastatin on renal function and ultrastructure changes after renal ischemia-reperfusion in rats.
METHODS:
Acute ischemic renal injury model was established (45 min of bilateral renal ischemia and reperfusion for 24 h). Thirty Male SD rats were randomly divided into 3 groups: sham operation group (control group or group C, without renal ischemia), renal ischemia-reperfusion group (ischemia-reperfusion group or group I, without ulinastatin), renal ischemia-reperfusion and ulinastatin intravenous injection group (ulinastatin group or group U). BUN level, serum creatinine values and renal ultrastructure were measured.
RESULTS:
Serum creatinine (167 +/- 39) micromol/L and BUN concentration (21 +/- 7) mmol/L in group I were significantly higher than those in group U: serum creatinine (116 +/- 13) micromol/L and BUN concentration (14.1 +/- 2.6) mmol/L (P < 0.05). The renal ultrastructure was greatly injured in group I, meanwhile, it was obviously ameliorated in group U.
CONCLUSION:
Ulinastatin greatly improved renal function and provides remarkable protection on renal ultrastructure after ischemia-reperfusion of kidney in rats.
AuthorsCong-cong Chen, Yan Zhou, Zi-ming Liu, Ju-mei Sun, Hui-hua Wang, Wei-dong Wu
JournalZhonghua wai ke za zhi [Chinese journal of surgery] (Zhonghua Wai Ke Za Zhi) Vol. 42 Issue 14 Pg. 877-80 (Jul 22 2004) ISSN: 0529-5815 [Print] China
PMID15363281 (Publication Type: Journal Article)
Chemical References
  • Glycoproteins
  • urinastatin
Topics
  • Animals
  • Glycoproteins (pharmacology)
  • Kidney (blood supply, drug effects, ultrastructure)
  • Male
  • Rats
  • Rats, Sprague-Dawley
  • Reperfusion Injury (drug therapy, pathology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: